A study published in Cellular and Molecular Gastroenterology and Hepatology highlights advances in understanding liver sinusoidal endothelial cells (LSECs) in cirrhosis, thanks to single-cell transcriptomics.
Key Findings of the Study
Led by Dr. Yasuko Iwakiri from Yale University, the research mapped transcriptomic profiles of liver endothelial cells (ECs) in both normal and cirrhotic mouse livers, revealing:
- 6 distinct LSEC clusters were identified, with 3 mapped to specific liver zones.
- Zone-specific transcriptomic changes, particularly in zone 3, which is most vulnerable to injury in cirrhotic conditions.
- Evidence of capillarization gene upregulation and decreased endocytic receptor expression, both of which contribute to LSEC dysfunction in cirrhosis.
This study underscores how LSEC dysfunction plays a pivotal role in the progression of liver fibrosis and cirrhosis, ultimately leading to severe clinical complications.
PELOBiotech offers high-quality Solutions
The research relied on products from PELOBiotech, including:
- Primary Human LSECs (PB-CH-153-5511)
- Cellovations Microvascular Endothelial Cell Growth Medium Kit(PB-MH-100-4099)
- Speed Coating Solution (PB-LU-000-0002-00)
These products ensured optimal cell growth, differentiation, and experimental reproducibility, enabling precise single-cell RNA sequencing (scRNA-seq) analysis of liver endothelial cells.
The Path Forward in Liver Research
By mapping the spatial distribution of heterogeneous liver ECs and their transcriptomic changes, this research paves the way for targeted therapeutic strategies against cirrhosis. Understanding zone-specific vulnerabilities and gene expression changes could lead to interventions that prevent or reverse liver fibrosis.
Congratulations to Dr. Iwakiri and her team for this contribution to biomedical science! PELOBiotech is proud to be part of this leading research that transforms our understanding of liver diseases.
Read full article here.
You might find this overview also helpful.
#LiverResearch #Cirrhosis #SingleCellTranscriptomics #PELOBiotech #BiomedicalScience